# BDMAI

> Bulk Drug Manufacturers Association of India


## Posts

- [WaveDigital Post3](https://bdmai.org/wavedigital-post3/): What Makes A Backlink A High-Quality Backlink?
- [WaveDigital Post2](https://bdmai.org/wavedigital-post2/): 6 Link-Building Strategies Franchises and Corporate Should Team Up On
- [WaveDigital post](https://bdmai.org/wavedigital-post/): How Backlink Penalty Hurts Your SEO and How to Avoid it
- [Hello world!](https://bdmai.org/hello-world/): Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

## Pages

- [New Home](https://bdmai.org/new-home/): BDMAI e-Marketing Portal
- [Resource Centre - Copy](https://bdmai.org/resource-centre-copy/): Resource Centre S.NO Title Info 1 BDMA Seminar on AI & Digitalisation in Bulk Drug Industry held on 6th Dec 2025-Presentatons Click Here 2 USP MONOGRAPHS Click Here 3 Import Data Click Here 4 Export Date Click Here 5 UCPMP 2024 Click Here 6 Charter on Corporate Responsibility for Environmental Protection Click Here 7 Minutes of Hyderabad Pharma City Public Hearing Click Here 8 Dr. Krishna Rao case judgement in Principal Bench NGT on 16.11.2017 Click Here 9 Judgment of NGT on Patancheru Pollution Case App. No. 90 of 2013 and others Click Here Infinite Right-to-Left Scrolling Marquee Important/Latest Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 BDMA TRAINING CENTRE-BROCHURE QMS BootCamp on Human Error Reduction LIST OF APPROVED MANUFACTURERS UNDER PLI SCHEME LIST OF APPROVED BULK DRUG MANUFACTURERS Bulk Drug Industry at a Glance 2021 Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 BDMA TRAINING CENTRE-BROCHURE QMS BootCamp on Human Error Reduction LIST OF APPROVED MANUFACTURERS UNDER PLI SCHEME LIST OF APPROVED BULK DRUG MANUFACTURERS Bulk Drug Industry at a Glance 2021
- [Internal Committee - Copy](https://bdmai.org/internal-committee-copy/): Internal Committee S.NO COMMITTEE NAME COMPANY NAME NAME OF PERSON Email Granules India Ltd Mr.Sridhar Reddy Karra sridharreddy.karra@granulesindia.com 1 Regulatory MSN Group Mr. Kadari  Ravinder Reddy   krreddy@msnlabs.com Laxai Life Sciences Pvt. Ltd. Mr. Narayana Reddy Jarugu jnarayanareddy@laxai.com Granules India Ltd  Mr.Kishore Reddy Alluri  kishorereddy.alluri@granulesindia.com Aurobindo Pharma Ltd Mr. Tapas Saha tapas.Saha@apitoria.com Apitoria Pharma Mr. Amar Kudale Amar.Kudale@apitoria.com 2 EHS Hetero Group Mr. Hari Bukia hari.b@hetero.com MSN Group  Mr. Muthyala Surender Reddy surender.muthyala@msnlabs.com Nagamalleshwar rao  S.NO. Date Title Document 1 03-07-25 Unfortunate incident at Sigachi Industries Click Here 2 04-07-25 Bulk Drug Park at Una, Himachal Pradesh – Interactive Meeting Click Here 3 24-06-25 Two-day Training Programme on Concentrated Solar Thermal Click Here 4 18-06-25 Launch of e-Marketing Portal to promote Indian Bulk Drug industry Click Here 5 26-05-25 Pharma Round Table Meeting – Greening of MSMEs under RAMP Click Here 6 24-05-25 Meeting with DDC, Zonal Office, CDSCO to sensitize on revised guidelines for export NoC Click Here 7 19-05-25 Applications are invited under PLI scheme to manufacture KSMs/ Drug Intermediates / API Click Here 8 08-05-25 Guidelines for obtaining Export NoC Click Here 9 03-04-25 Nomination for Internal Committee Click Here 10 02-04-25 Workshop for Bench Chemists Click Here 11 01-04-25 Simplification of License Procedures Click Here 12 24-03-25 Online Application for implementation Schedule M Click Here 13 24-03-25 Special Office by Avila International Click Here 14 20-03-25 ICH Guidelines –Q7 in Telugu Version Click Here 15 18-03-25 Free In-House Up-Skilling Programme Click Here 16 11-03-25 New Guidelines for obtaining NoC Click Here 17 07-03-25 Launch of PRIP Scheme of DoP Click Here 18 18-02-25 Allotment of Land at Green Pharma City, Telangana Click Here 19 13-02-25 Implementation of Schedule M –Online Demo Click Here 20 28-01-25 MoU Signing Ceremony between BDMA & TGCHE Click Here 21 21-01-25 Delays in obtaining URN from NCB Click Here 22 08-01-25 Pharma MSME Industry Meet-24.01.2025 Click Here 23 04-01-25 Interaction with USP India Team Click Here 24 16-12-24 BDMA News Letter- Material Contribution by Members Click Here 25 13-12-24 Sectoral Plan for effective logistics- Pharma Click Here 26 09-12-24 Availability of QC manpower trained in BDMA T&T Centre Click Here
- [Representations](https://bdmai.org/representations/): Representations Sl No. Subject Date Document     1 .                      NICDC–Rejuvenation of Export-Oriented Industrial Clusters                               09.04.2026                              Click Here      2 .                        Request  to curb abnormal rise in the prices of raw materials                           04.04.2026                                Click Here      3 .                        Representation to TGPCB & APPCB on Change of Product Mix                        26.03.2026                                Click Here      4 .                        Request for details of land at Orvakal, Kurnool district.AP                                25.03.2026                                Click Here      5 .                         Power Distribution Companies  for submission of Occupancy Certificates     23.02.2026                              Click Here      6 .                          Non-requirement of e-BRC   for INR Payments under Deemed Exports           13.01.2026                                 Click Here      7.                          Scheduling of drugs or chemicals under NDPS regarding                                   13.01.2026                                 Click Here      8.                       Delays in obtaining NOCs for re-imports – Request for uniform SOPs               09.01.2026                               Click Here      9.                          Suggestions/Inputs to CPCB for Common EPR Portal                                             08.01.2026                              Click Here      10.                       Response received from DGFT on our Repr.  on deemed export claims             02.01.2026                               Click Here      11.                        Representation to DGFT on deemed export claims                                               22.12.2025                               Click Here       12.                       Representaton to Hon’ble Min. for I&C,Telangana on GO Ms. No.27                 17.12.2025                                Click Here       13.                       Request for Amendment to Para 4.12 of Foreign Trade Policy                            09.12.2025                               Click Here      14.                        Allocation of land for Bulk Drug Industries in Kanigiri MSME Park                    10.11.2025                                 Click Here     15.                       Allotment of Land to MSME  in Nakkapalli Bulk Drug Park                                    27.10.2025                              Click Here      16                           Status quo on GST rates for APIs & Intermediates                                                 24.10.2025                              Click Here       17                       MoEF Notification on COD Discharge Limits for Marine Outfalls                        06.10.2025                              Click Here       18                      Request for off-line issue of WHO GMP (Copps)                                                12.09.2025                             Click Here         19                      Request for off-line issue of WHO GMP (Copps)                       
- [Internal Committee](https://bdmai.org/internal-committee/): Internal Committee S.NO COMMITTEE NAME COMPANY NAME NAME OF PERSON Email 1 Regulatory Granules India Ltd Mr.Sridhar Reddy Karra sridharreddy.karra@granulesindia.com 2 Regulatory MSN Group Mr. Kadari  Ravinder Reddy   krreddy@msnlabs.com 3 Regulatory Laxai Life Sciences Pvt. Ltd. Mr. Narayana Reddy Jarugu jnarayanareddy@laxai.com 4 EHS Granules India Ltd Mr.Kishore Reddy Alluri kishorereddy.alluri@granulesindia.com 5 EHS Aurobindo Pharma Ltd Mr. Tapas Saha tapas.Saha@apitoria.com 6 EHS Apitoria Pharma Mr. Amar Kudale amar.Kudale@apitoria.com 7 EHS Hetero Group Mr. Hari Bukia hari.b@hetero.com 8 EHS MSN Group  Mr. Muthyala Surender Reddy  surender.muthyala@msnlabs.com 9 EHS MSN Group Mr. Nagamalleshwar rao  malleswararao.sandepudi@msnlabs.com 10 EHS Laxai Life Sciences Pvt. Ltd.  Mr. Nagendra Babu B nagendrababu.b@laxai.com 11 Commercial Granules India Ltd Mr.Sathyanarayana Jettem  jsnarayaana@granulesindia.com 12 Commercial Rampex Labs Pvt Ltd Mr. G Venkateswara Rao gvrao@rampexlabs.com 13 Exports Granules India Ltd Mr.Khaleel Shaik  khaleel.shaik@granulesindia.com 14 Exports MSN Group Mr. Kalvakol Ragava Reddy  raghavareddy.k@msnlabs.com 15 Regulatory & Exports Piramal Pharma Ltd Mr. Minoo Biju minoo.biju@piramal.com 16 Regulatory & Exports Piramal Pharma Ltd Mr. Neelam Sharma neelam.sharma@piramal.com
- [Updates](https://bdmai.org/updates/): Updates S.NO. Title Document 1 Industry Performance Metrics: Insights from US FDA Inspection Data Click Here 2 The Indian Bulk Drug Industry Holds Strategic Importance in Strengthening Global Supply Chain Resilience Click Here 3 Optimising Pharmaceutical Process Click Here 4 Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Click Here 5 Information on Delta Carbon – Advanced bio based Material Click Here 6 Energy Efficient Cooling Solutions for API From Thermax Click Here 7 Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad Click Here 8 New Drug Therapy Approvals 2024 Click Here 9 Fortifying API Supply Chains 2025 and Beyond: Aligning Current Strengths with Future Opportunities for Better Patient Outcomes Click Here 10 Process Validation: The Life Cycle Approach Click Here 11 The NDMA Story: Lessons Learned from a Global Pharmaceutical Challenge Click Here 12 Future Forward: How Gender Diversity Can Transform the Indian Bulk Drug Industry Click Here
- [Home - Copy](https://bdmai.org/home-copy/): CSS Slider with Synced Radio Buttons Meeting with Mr.Alok Kumar IAS ,Prl.Secy Medical (UP) on 25rh April 2025.at BDMA Office, Sanathnagar MoU with TGCHE on 8th February 2025 SME InFocus Meet on 24th Jan 2025 Industry Interaction with USP India Team on 9th Jan 2025 India UAE and Australia Trade Agreements 23.April.2022 Workshop on Analytical Method Development Nitrosamine Impurities & Process Safety 2nd Feb 2024 Meeting with USP at-BDMA T&T Centre on 2nd Feb 2024 Meeting with USFDA India Team on 26th Feb 2024 Updates Optimising Pharmaceutical Process Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Information on Delta Carbon- Advanced bio based Material Energy Efficient Cooling Solutions for API From Thermax Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad New Drug Therapy Approvals 2024 Optimising Pharmaceutical Process Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Information on Delta Carbon- Advanced bio based Material Energy Efficient Cooling Solutions for API From Thermax Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad New Drug Therapy Approvals 2024 Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad View All Infinite Right-to-Left Scrolling Marquee Latest Circulars Availability of QC Manpower trained in BDMA T & T Center Sectoral Plan for Effective Logistics – Pharma Sector BDMAI News Letter – Material contribution by Members Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m. Pharma MSME Industry Meet – 24.1.2025 Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025 Allotment of land in Green Pharma City, Telangana Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies ICH Guidelines- Q7- Telugu Translated version Special offer by Avila International – Travel Package – CPhI China Online Application for implementation of Schedule M Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis Workshop for Bench Chemists Nomination for Internal Committees of BDMAI Availability of QC Manpower trained in BDMA T & T Center Sectoral Plan for Effective Logistics – Pharma Sector BDMAI News Letter – Material contribution by Members Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m. Pharma MSME Industry Meet – 24.1.2025 Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025 Allotment of land in Green Pharma City, Telangana Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies ICH Guidelines- Q7- Telugu Translated version Special offer by Avila International – Travel Package – CPhI China Online Application for implementation of Schedule M Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis Workshop for Bench Chemists Nomination for Internal Committees of BDMAI CSS Slider with Synced Radio Buttons Meeting with Mr.Alok Kumar IAS ,Prl.Secy Medical (UP) on 25rh April 2025.at BDMA Office, Sanathnagar MoU with TGCHE on 8th February 2025 SME InFocus Meet on 24th Jan 2025 Felicitation to Sri GV Prasad on 18th September 2025 Office Bearers of BDMA Workshop on Analytical Method Development Nitrosamine Impurities & Process Safety 2nd Feb 2024 Meeting with USP at-BDMA T&T Centre on 2nd Feb 2024 Meeting with USFDA India Team on 26th Feb 2024 Your Caption for Slide 9 – Add your image URL and caption here Your Caption for Slide 10 – Add your image URL and caption here Your Caption for Slide 11 – Add your image URL and caption here Your Caption for Slide 12 – Add your image URL and caption here Your Caption for Slide 13 – Add your image URL and caption here Your Caption for Slide 14 – Add your image URL and caption here Your Caption for Slide 15 – Add your image URL and caption here Your Caption for Slide 16 – Add your image URL and caption here Updates Optimising Pharmaceutical Process Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Information on Delta Carbon- Advanced bio based Material Energy Efficient Cooling Solutions for API From Thermax Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad New Drug Therapy Approvals 2024 Optimising Pharmaceutical Process Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Information on Delta Carbon- Advanced bio based Material Energy Efficient Cooling Solutions for API From Thermax Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad New Drug Therapy Approvals 2024 View All Welcome to BDMAI   The Bulk Drug Manufacturers Association (India) was formed in 1991 with Hyderabad as its Head Quarters. This is an all India body representing most of the Bulk Drug Manufacturers of India. The Association works for the consolidation of gains of the industry and serves as a coordinator and catalyst between the government and the industry for the growth of the industry. About Us History Role of BDMA Objectives BDMA T&T Centre UNIFORM CODE OF PHARMACEUTICAL MARKETING PRACTICES ATTENTION MEMBERSThe Department of Pharmaceuticals has forwarded the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) informing that it is being implemented to all pharmaceutical manufacturers (COPY AVAILABLE IN PORTALS OF BDMA WEBSITE)   Members will be aware that DoP has published a voluntary Code of Marketing Practices quite some time ago for Pharmaceutical companies and is committed to
- [Circulars](https://bdmai.org/circulars/): Circulars Date Title Document 02-04-26 Customs Duty waived off on various Chemicals Click Here 24-03-26 Interactive Meeting with Commerce Secretary, Government of India Click Here 10-03-26 Greening of MSMEs – Free Technical Assistance – An initiative of Telangana State Government under RAMP programme. Click Here 06-03-26 BDMAI’s proposal to organize a Pavilion at CPhI India 2026 – Request for expression of Interest to participate in the Pavilion Click Here 06-03-26 Technical Meet on ‘ Strategies for Sustainable Waste Water Treatment & ZLD Systems – March 12-13 2026 Click Here 03-03-26 A Free Skill Development Course on Environmental Sustainability for MSMEs organized by ICC Click Here 23-02-26 Industry Summit – Organized by Chemical Engineering Department of IIT, Hyderabad -28.02.2026 Click Here 09-02-26 Bio-Asia – Special Discounted Delegate Fee for BDMAI Members. Click Here 06-02-26 Scheme for promotion of Domestic Production of Fermentation based Bulk Drugs-Inputs required for DoP Click Here 05-02-26 Seminar on “Best Practices to minimize Chloromethane Emissions & SOPs to utilize Hazardous Wastes in Bulk Drug Industry” – 13.2.2026 Click Here 02-02-26 Hyderabad Integrated MSW Ltd for collection of Industrial MSW Wastes Click Here 21-01-26 Conference on ‘Air Quality Management in Hyderabad’ by Telangana State Government Click Here 29-12-25 Lalitpur Pharma Park in UP – Interaction with Senior Government officials on 6.1.2026 Click Here 10-12-25 Awareness Programme – Financial Schemes of SIDBI, MSME schemes for Pharma Industry & (NAPS) – 16th December 2025 Click Here 28-11-25 Seminar on “AI & Digitalization in Bulk Drug Manufacturing” – 6th December 2025, Hyderabad Click Here 24-11-25 Revision in the User Charges for Collection of Hazardous Waste Click Here 24-11-25 Block Your Diary – Seminar on “AI & Digitalization in Bulk Drug Manufacturing” Click Here 24-11-25 Availability of Trained Candidates Click Here 11-11-25 Mastering Clean Room Compliances – A Roundtable Conference – 14.11.2025 Click Here 03-11-25 Interaction with Hon’ble Chief Minister of Punjab – 11.11.2025 Click Here 31-10-25 12th India Pharma Awards by CPhI India Click Here 27-10-25 SIDBI offers Term / Soft Loans under Arogya Scheme for Pharmaceutical Industry Click Here 07-10-25 Pharma Bulk Drug Manufacturing Summit – 15th October 2025 at Hotel Radisson Blu, Banjara Hills, Hyderabad Click Here 29-09-25 Recruitment Drive for fresh B.Sc./M.Sc./ B.Tech. / M. Tech/ B. Pharm / M Pharm ITI/Diploma candidates at Palamuru University on 11th October 2025 Click Here 22-09-25 Minimum Import Price on Potassium Clavulanate and its intermediates Click Here 19-09-25 New Team of Office Bearers of BDMAI Click Here 16-09-25 Inputs required – Use of Perfluorooctyl Iodide for production of Perfluorooctyl Bromide Click Here 11-09-25 Webinar organized by DGTS-AEO Programme & MOOWR Scheme Click Here 05-09-25 Availability of Manpower – Supply Chain Executives & Warehouse Executives Click Here 30-08-25 AGM 2025 Notice Click Here 20-08-25 Online demonstration of new portal for OCEMS by CPCB Click Here 13-08-25 Availability of LSSSDC Trained Candidates for recruitment Click Here 03-07-25 Unfortunate incident at Sigachi Industries Click Here 04-07-25 Bulk Drug Park at Una, Himachal Pradesh – Interactive Meeting Click Here 24-06-25 Two-day Training Programme on Concentrated Solar Thermal Click Here 18-06-25 Launch of e-Marketing Portal to promote Indian Bulk Drug industry Click Here 26-05-25 Pharma Round Table Meeting – Greening of MSMEs under RAMP Click Here 24-05-25 Meeting with DDC, Zonal Office, CDSCO to sensitize on revised guidelines for export NoC Click Here 19-05-25 Applications are invited under PLI scheme to manufacture KSMs/ Drug Intermediates / API Click Here 08-05-25 Guidelines for obtaining Export NoC Click Here 03-04-25 Nomination for Internal Committee Click Here 02-04-25 Workshop for Bench Chemists Click Here 01-04-25 Simplification of License Procedures Click Here 24-03-25 Online Application for implementation Schedule M Click Here 24-03-25 Special Office by Avila International Click Here 20-03-25 ICH Guidelines –Q7 in Telugu Version Click Here 18-03-25 Free In-House Up-Skilling Programme Click Here 11-03-25 New Guidelines for obtaining NoC Click Here 07-03-25 Launch of PRIP Scheme of DoP Click Here 18-02-25 Allotment of Land at Green Pharma City, Telangana Click Here 13-02-25 Implementation of Schedule M –Online Demo Click Here 28-01-25 MoU Signing Ceremony between BDMA & TGCHE Click Here 21-01-25 Delays in obtaining URN from NCB Click Here 08-01-25 Pharma MSME Industry Meet-24.01.2025 Click Here 04-01-25 Interaction with USP India Team Click Here Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Add Your Heading Text Here Add Your Heading Text Here Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. This is the First string, Second string, Third string of the sentence. Circulars Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Add Your Heading Text Here Add Your Heading Text Here Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. This is the First string, Second string, Third string of the sentence. Click here Circulars Date Title Document 23-02-26 Industry Summit – Organized by Chemical Engineering Department of IIT, Hyderabad -28.02.2026 Click Here 09-02-26 Bio-Asia – Special Discounted Delegate Fee for BDMAI Members. Click Here 06-02-26 Scheme for promotion of Domestic Production of Fermentation based Bulk Drugs-Inputs required for DoP Click Here 05-02-26 Seminar on “Best Practices to minimize Chloromethane Emissions & SOPs to utilize Hazardous Wastes in Bulk Drug Industry” – 13.2.2026 Click Here 02-02-26 Hyderabad Integrated MSW Ltd for collection of Industrial MSW Wastes Click Here 21-01-26 Conference on ‘Air Quality Management in Hyderabad’ by Telangana State Government Click Here 29-12-25 Lalitpur Pharma Park in UP – Interaction with Senior Government officials on 6.1.2026 Click Here 10-12-25 Awareness Programme – Financial Schemes of SIDBI, MSME schemes for Pharma Industry & (NAPS) – 16th December 2025 Click Here 28-11-25 Seminar on “AI & Digitalization in Bulk Drug Manufacturing” – 6th December 2025, Hyderabad Click Here 24-11-25 Revision in the User Charges for Collection of Hazardous Waste Click Here 24-11-25 Block Your Diary – Seminar on “AI & Digitalization in Bulk Drug Manufacturing” Click Here 24-11-25 Availability of
- [Schemes PRIP](https://bdmai.org/schemes-prip/): Schemes PRIP Lunch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India We wish to bring to the notice of Members that Department of Pharmaceuticals, Government of India launched a new scheme called Promotion of Research & Innovation in Pharma MedTech (PRIP) today.   Salient features of the Scheme are given below:   1. There are six (6) priority areas viz., New Chemical Entity/New Biological entity/new phytochemical entity, Complex generics/biosimilars, Precision Medicine, Medical Devices, Orphan Drugs and Drug Development for AMR   2. There are three (3) categories of funding:   a) Category I – Funding up to 35% of project cost or Rs.125 crores, whichever is less. Any Company with not less than Rs. 1000 crore annual revenue and with R&D expenditure of 3-5% is eligible to apply. The project has to be undertaken in collaboration with any of the notified Centers of Excellence. Only 9 (nine) companies will be selected   b) Category II: Funding up to 35% project cost Rs. 100 crores, whichever is less. Any company working on R&D projects of above priority areas is eligible to apply, provided the project is at TRL (Technology Readiness Level) 5 or 6. Thirty (30) projects will be selected.   c) Category III: Funding up to Rs. 1 crore per project. Start Ups and MSMEs working on project in the priority areas are eligible to apply for projects from TRL 1-4. One hundred Twenty five (125) projects will be selected.   d) Last date for submission of Expression of Interest is 7th April 2025. Expression of Interest has to be submitted through Web page of Department of Pharmaceuticals only, which will be made available two week before the last date.   e) In case members would like to be notified about the launch of webpage to submit their interest, please log on to Opt in for PRIP “Digital EoI” launch notification and submit your contact details.   For more details about Scheme, benefit sharing, centers of excellence, application format etc., please visit PRIP Scheme | Department of Pharmaceuticals
- [Govt Schemes/Notifications](https://bdmai.org/govt-schemes-notifications/): Govt Schemes/Notifications S.NO. Title Document 1 Customs Circular No.10 Levy of fee for amendment or cancellatlon of export docirments in cases of withdrawal of export consignments due to force maieure circumstances Click Here 2 Customs Circular No.9 of 2026 Return of export cargo from international waters due to closure of the Strait of Hormuz Click Here 3 Customs Circular No.8 of 2026 Extension of Deferred Payment of Customs Duty benefits to ‘Eligible Manufacturer Importer’ (EMI) Click Here 4 Rationalizing the requirement of green belt cover for IE/parks and Individual Industries dated 29-11-2025 Click Here 5 Implementation of the Revised Schedule M Notification dated 7-11-2025 Click Here 6 PLI Scheme 14th May 2025 Notification Click Here 7 Guidance document Export NOC 7.5.2025 Click Here 8 Lunch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India Click Here 9 MOOWR Scheme Click Here 10 Approved Operational Guidelines (PRIP) Click Here    6              Gazette G.S.R. 365(E)  Plastic Waste Management Rules 3rd June, 2025                                                                                                              Click Here    7              Employment Linked Incentive Scheme Ministry of Labour & Employment                                                                                                              Click Here    8              Public Notice on Fixation of New SION Norm   July 29,2025                                                                                                                                      Click Here
- [Gallery](https://bdmai.org/gallery/): Gallery Lalitpur, UP Pharma Conclave 3rd Feb 2026 SME InFocus Meet on 24-01-25 Meeting with USP at BDMA T&T Centre on 02-02-24 Industry Interaction with USP India Team on 09-01-25 BDMA Delegates at NCL-Pune- 12-12-23 Meeting with USFDA India Team on 26-02-25 Meeting with USFDA India Team on 26-02-24 Launching of BDMA IICT Sample Collection Centre India UAE & Australia Trade Agreements 23-04-2022 Meeting Meeting Meeting Meeting India UAE & Australia Trade Agreements 23-04-2022 Launching of BDMA IICT Sample Collection Centre Meeting with USFDA India Team on 26-02-24 Meeting with USFDA India Team on 26-02-25 BDMA Delegates at NCL-Pune- 12-12-23 Industry Interaction with USP India Team on 09-01-25 Meeting with USP at BDMA T&T Centre on 02-02-24 SME InFocus Meet on 24-01-25
- [Government Notifications](https://bdmai.org/government-notifications/): Government Notifications PLI Scheme Vitamin B1 Constitution of GST Facilitation Cell Latest 120 Directions on Revised CEPI Implementation of Revised Schedule M Notification
- [Head Office](https://bdmai.org/head-office/): Head Office BULK DRUG MANUFACTURERS ASSOCIATION (INDIA)   Regd. Office: C-25, Industrial Estate, Sanathnagar,Hyderabad – 500 018, INDIA    +91 – 40 – 2370 3910 | 2370 6718 | 2370 4804    info@bdmai.org | ed@bdmai.org    www.bdmai.org Key Contacts Smt.M. Roja Rani, Executive Director Sri Ch. Ramasanyasi Rao, Manager Sri K. Sathish, Accountants Manager
- [Executive Committee](https://bdmai.org/executive-committee/): Past Presidents & Executive Committee Members S.NO NAME COMPANY NAME (M/S) DESIGNATION 1 SRI RK AGRAWAL NAKODA CHEMICALS PVT LTD PATRON,BDMA 2 SRI V.V.KRISHNA REDDY SRIKRISHNA PHARMACEUTICALS LTD PATRON, BDMA 3 SRI. M. JAYANT TAGORE SYNTHOKEM LABS. PVT. LTD PATRON, BDMA 4 SRI. K. NITYANANDA REDDY AUROBINDO PHARMA LTD PATRON, BDMA 5 SRI M.NARAYANA REDDY VIRCHOW LABORATORIES LTD PATRON, BDMA 6 Dr. B. PARTHASARADHI REDDY HETERO DRUGS LTD PATRON, BDMA 7 Dr.VENKAT JASTI SUVEN LABORATORIES LTD PATRON, BDMA  8 SRI PV RAMA PRASAD REDDY AUROBINDO PHARMACEUTICALS LTD PATRON, BDMA 9 Dr.N.VENKATA REDDY VIRCHOW LABORATORIES LTD PATRON,BDMA 10 SRI S.MOHANCHAND DADHA DADHA PHARMACEUTICALS LTD PATRON,BDMA 11 Dr. V V SUBBA REDDY SRIKRISHNA PHARMACEUTICALS LTD PATRON,BDMA 12 SRI C.CHANDRASEKHARA REDDY STANDARD ORGANICS LTD PATRON,BDMA 13 Dr.PV Appaji MEENAXY PHARMA PVT LTD HONORARY ADVISOR SL NO             NAME         COMPANY NAME(M/s)                    DESIGNATION 1 SRI. TBNV SUNDER RAO VISHNU CHEMICALS LTD., EXECUTIVE COMMITTEE MEMBER 2 SRI. K. RAVINDER REDDY MSN LABORATORIES PVT LTD EXECUTIVE COMMITTEE MEMBER 3 SRI. V. MADHUKAR REDDY S.M.LABS PVT LTD EXECUTIVE COMMITTEE MEMBER 4 SRI. P. MADANMOHAN REDDY AUROBINDO PHARMA LTD.,  EXECUTICE COMMITTEE MEMBER 5 SRI ANUP AGARWAL SREEPATHI LABS PVT LTD EXECUTIVE COMMITTEE MEMBER 6 SRI. G. HEMANTH REDDY BALAJI AMINES LTD EXECUTIVE COMMITTEE MEMBER 7 SRI. NAGARJUN CHAKILAM MAITHRI DRUGS PVT LTD EXECUTIVE COMMITTEE MEMBER 8 SRI KVSR SESHU KUMAR PURVIEW LIFESCIENCES P LTD EXECUTICVE COMMITTEE MEMBER 9 SRI V ABHINAV KUMAR BALAJI FORMULATIONS PVT.LTD EXECUTIVE COMMITTEE MEMBER 10 SRI N. HARDEV METROCHEM API DIVISION PVT LTD EXECUTIVE COMMITTEE MEMBER 11 SRI M. BALA SUBBA REDDY VIRUPAKSHA ORGANICS PVT LTD EXECUTIVE COMMITTEE MEMBER 12 Dr.JAGADEESH BABU R BIOPHORE PVT LTD EXECUTIVE COMMITTEE MEMBER 13 CH AVINASH SHOURY AZICO BIOPHORE PVT LTD EXECUTIVE COMMITTEE MEMBER 14 SRI J M PRAKASH FLEMING LABORATORIES PVT LTD EXECUTIVE COMMITTEE MEMBER
- [Office Bearers](https://bdmai.org/office-bearers/): Office Bearers sri ch A.P. RAMESWARA RAO National President SRI M NARAYANA REDDY Sr.VICE PRESIDENT SRI R SRINIVASA RAJU VICE PRESIDENT (SOUTH) SRI BR SIKRI VICE PRESIDENT (NORTH) SRI NARESH D GUPTA VICE-PRESIDENT (WEST) SRI LV SUNIL SECRETARY SRI P ANUPVEER TREASURER Dr.RAMACHANDRA REDDY YELURI JOINT Secretary
- [Objectives](https://bdmai.org/objectives/): Objectives “The Association works   for consolidation  of  the  gains of the industry and serves  as  a catalyst between Government and the  Industry  on the  various issues for the growth of the Industry”: Strengthening India’s Pharmaceutical Industry Build on India’s existing strength in manufacturing and distribution. Significantly enhance R&D capabilities. Become a leading player in the global pharmaceutical market. Serving as a Common Forum Promote discussions on key issues affecting the Bulk Drug Industry in India. Provide a platform for members to formulate collective views on national, economic, financial, and commercial policies impacting industry growth. Encouraging Collaboration Among Members Foster mutual help and cooperation among members. Advocacy & Representation Represent members’ collective opinions on industry-related matters. Engage with State and Central Government authorities to influence policy decisions affecting the bulk drug industry. Information Sharing & Publications Disseminate relevant information to members. Publish and circulate papers, periodicals, books, and circulars beneficial to the industry. Innovation & Research Promote the discovery and investigation of inventions beneficial to the Bulk Drug Industry. Support the development of new drugs and process improvements. Market Development Develop strategies to enhance indigenous and export markets for Indian Bulk Drugs Quality & Research Facilities Establish and maintain libraries and laboratories for testing bulk drugs and allied products. Set up R&D centers for drug development and process improvements. Develop Hi-tech Research & Training Centers for industry advancement. Funding & Support Accept donations and contributions from government bodies, philanthropic institutions, organizations like FAO, WHO, and individuals. Legal & General Activities Undertake all lawful activities aligned with the Association’s objectives.
- [Management Committee](https://bdmai.org/management-committee/): Office Bearers SRI CH A.P. RAMESWARA RAO National President SRI. M. Narayana Reddy Sr.VICE PRESIDENT SRI. R.Srinivasa Raju vice president (south) SRI. BR Sikri VICE PRESIDENT (NORTH) SRI NARESH D GUPTA VICE-PRESIDENT (WEST) SRI LV SUNIL SECRETARY SRI P.ANUPVEER TREASURER Dr.RAMACHANDRA REDDY YELURI JOINT Secretary
- [News Bulletin](https://bdmai.org/news-bulletin/): News Bulletin Title Info April 2026 Click Here March 2026 Click Here February 2026 Click Here January 2026 Click Here December 2025 Click Here November 2025 Click Here October 2025 Click Here September 2025 Click Here August 2025 Click Here July 2025 Click Here June 2025 Click Here May 2025 Click Here April 2025 Click Here March 2025 Click Here February 2025 Click Here January 2025 Click Here August 2024 – September 2024 Click Here June 2024 – July 2024 Click Here
- [Resource Centre](https://bdmai.org/resource-centre/): Resource Centre S.NO Title Info 1 Highlights of Budget 2026-27 Click here 2 BDMA Seminar on AI & Digitalisation in Bulk Drug Industry held on 6th Dec 25- presentations Click Here 2 Uzbekistan Market Report Click Here 3 ICH Guidelines – Q7 – Telugu version Click Here 4 Import Data by Country April-September 2025 Click Here 5 USP MONOGRAPHS Click Here 6 Import Data by HS Code April-Sep 2025 Click Here 7 Exports Data by Country April-September 2025 Click Here 8 Exports Data by HS Code April-September 2025 Click Here 9 Charter on Corporate Responsibility for Environmental Protection Click Here 10 Minutes of Hyderabad Pharma City Public Hearing Click Here 11 Dr. Krishna Rao case judgement in Principal Bench NGT on 16.11.2017 Click Here 12 Judgment of NGT on Patancheru Pollution Case App. No. 90 of 2013 and others Click Here Tab #1 Tab #2 Tab #3
- [BDMA T&T Centre](https://bdmai.org/bdma-tt-centre/): BDMA T&T Centre S.NO Title Info 1 REDOX LABS-BDMAI-DDUGKY-EGMM-TG 2025 Leaflet Click Here Brochure Brochure Click Here
- [History](https://bdmai.org/history/): History The Bulk Drug Manufacturers Association (India) (BDMA(I)) was established in 1991 as an all-India body to serve the needs of the bulk drug industry, with its headquarters in Hyderabad. As of March 31, 2015, the association had a total membership base of 412. During the year 2015-16, 78 new Ordinary/Associate Members were added, bringing the total membership to 490 as of March 31, 2016.
- [About Us](https://bdmai.org/aboutus/): About Us To provide a platform for discussion among member industries on various subjects concerning the Bulk Drug Industry, focusing on formulating industry views on national, technical, economic, and commercial policies that impact its growth. To assist, cooperate, and represent the collective opinion of association members in the formulation and execution of legislative measures by state or central government authorities/regulators that directly or indirectly affect the Bulk Drug sector.
- [Contact Us](https://bdmai.org/contact-us/): Contact Us  Bulk Drug Manufacturers Association (India) C-25, Industrial Estate, Sanathnagar,Hyderabad – 500 018, INDIA   info@bdmai.org ed@bdmai.org       +91 – 40 – 2370 6718 +91 – 40 – 2370 4804    
- [Home](https://bdmai.org/): Click here to Become Member of BDMAI |Click here to access e-Marketing Portal CSS Slider with Synced Radio Buttons Meeting with Mr.Alok Kumar IAS ,Prl.Secy Medical (UP) on 25rh April 2025.at BDMA Office, Sanathnagar MoU with TGCHE on 8th February 2025 SME InFocus Meet on 24th Jan 2025 Industry Interaction with USP India Team on 9th Jan 2025 India UAE and Australia Trade Agreements 23.April.2022 Workshop on Analytical Method Development Nitrosamine Impurities & Process Safety 2nd Feb 2024 Meeting with USP at-BDMA T&T Centre on 2nd Feb 2024 Meeting with USFDA India Team on 26th Feb 2024 Updates Optimising Pharmaceutical Process Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Information on Delta Carbon- Advanced bio based Material Energy Efficient Cooling Solutions for API From Thermax Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad New Drug Therapy Approvals 2024 Optimising Pharmaceutical Process Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI) Information on Delta Carbon- Advanced bio based Material Energy Efficient Cooling Solutions for API From Thermax Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad New Drug Therapy Approvals 2024 Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad View All Welcome to BDMAI   The Bulk Drug Manufacturers Association (India) was formed in 1991 with Hyderabad as its Head Quarters. This is an all India body representing most of the Bulk Drug Manufacturers of India. The Association works for the consolidation of gains of the industry and serves as a coordinator and catalyst between the government and the industry for the growth of the industry. About Us History Role of BDMA Objectives Welcome to BDMAI   The Bulk Drug Manufacturers Association (India) was formed in 1991 with Hyderabad as its Head Quarters. This is an all India body representing most of the Bulk Drug Manufacturers of India. The Association works for the consolidation of gains of the industry and serves as a coordinator and catalyst between the government and the industry for the growth of the industry. About Us History Role of BDMA Objectives BDMA T&T Centre BDMA T&T Centre Meeting With USP at BDMA T&T Centre on 02-02-24 Meeting With USP at BDMA T&T Centre on 02-02-24 Meeting With USP at BDMA T&T Centre on 02-02-24 Meeting With USP at BDMA T&T Centre on 02-02-24 Meeting With USP at BDMA T&T Centre on 02-02-24 Meeting With USP at BDMA T&T Centre on 02-02-24 Meeting With USP at BDMA T&T Centre on 02-02-24 Resource Centre Top 50 importing companies Read More… Regulatory Agency Read More… New Drug Theraphy Approvals Read More… Resource Centre Top 50 importing companies Read More… Regulatory Agency Read More… New Drug Theraphy Approvals Read More… From the Desk of President ~BDMAI It is gratifying to note that I had been elected as National President along with other senior leaders who were elected as Office Bearers and Executive Committee Members in the Annual General Body Meeting held on 18th of September 2025. This kind gesture by all of you reminds me to be humble and discharge my duties with full responsibility. ~MR. CH AP RAMESWARA RAO National President From the Desk of President ~BDMAI It is gratifying to note that I had been elected as National President along with other senior leaders who were elected as Office Bearers and Executive Committee Members in the Annual General Body Meeting held on 18th of September 2025. This kind gesture by all of you reminds me to be humble and discharge my duties with full responsibility. ~MR. CH AP RAMESWARA RAO National President Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.


[comment]: # (Generated by Hostinger Tools Plugin)